These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
    Author: Holubarsch C, Hasenfuss G, Thierfelder L, Heiss HW, Just H.
    Journal: Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895.
    Abstract:
    The comparison of two invasive studies using intravenous application of the phosphodiesterase enoximone demonstrated unchanged cardiac output in patients with dilated cardiomyopathy NYHA II-III, and increased cardiac output (from 3.22 +/- 1.15 to 5.04 +/- 2.05 l/min; p less than 0.01) in acute heart failure. This comparison of hemodynamic parameters in addition to studies on myocardial oxygen consumption support the use of intravenous enoximone in acute heart failure, whereas the long-term application of enoximone in chronic heart failure is judged to be critical.
    [Abstract] [Full Text] [Related] [New Search]